Cargando…
Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
COVID-19 is characterized by predominant respiratory and gastrointestinal symptoms. Liver enzymes derangement is seen in 15–55% of the patients. Advanced age, hypertension, diabetes, obesity, malignancy, and cardiovascular disease predispose them to severe disease and the need for hospitalization. D...
Autores principales: | Sharma, Praveen, Kumar, Ashish, Anikhindi, ShriHari, Bansal, Naresh, Singla, Vikas, Shivam, Khare, Arora, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774459/ https://www.ncbi.nlm.nih.gov/pubmed/33398223 http://dx.doi.org/10.1016/j.jceh.2020.12.006 |
Ejemplares similares
-
Reply to the letter of Singh and Singh in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis” (Kumar et al.)
por: Kumar, Ashish, et al.
Publicado: (2020) -
Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis
por: Kumar, Ashish, et al.
Publicado: (2020) -
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
por: Kumar, Ashish, et al.
Publicado: (2020) -
Kikuchi-Fujimoto Disease: A Rare Presentation with Localized Iliac Lymphadenitis
por: Anikhindi, Shrihari Anil, et al.
Publicado: (2017) -
Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India
por: Kumar, Ashish, et al.
Publicado: (2017)